BCIS ACI 2020: TAVI Should Now Be the Default Treatment for Patients with Symptomatic Aortic Stenosis

Published: 13 March 2020

  • Views:

    Views Icon 35
  • Likes:

    Heart Icon 7
  • episode_image
    Now Playing
    Part 2
    Pro Argument
    David Hildick-Smith
    Up Next
  • episode_image
    6m 45s
    Part 4 Panel Discussion
    Clare Appleby, Simon Redwood, Gregg W Stone, Andrew SP Sharp, Rob Butler, Marjan Jahangiri
Average (ratings)
No ratings
Your rating

Overview

In this video series chairs, Prof Simon Redwood (Guy’s and St Thomas’ NHS Foundation Trust, London, UK) and Dr Clare Appleby (Liverpool Heart and Chest Hospital, Liverpool, UK) ask the question “Should TAVI be the default treatment for patients with symptomatic aortic stenosis?". From BCIS ACI’s audience and introducing the panel of the debate. Further through the series Prof David Hildick-Smith (Sussex Cardiac Centre, Brighton, UK) argues for an interventional approach whilst Prof Marjan Jahangiri (St George's University Hospitals NHS Foundation Trust, London, UK) argues that surgery, SAVR should be considered based on life expectancy in the treatment of patients with symptomatic aortic stenosis. The series concludes with the panel and chairs reflecting on the data and recent arguments delivered. 

This content was provided by the courtesy of BCIS.

More from this programme

Part 1

Introduction and preliminary poll

Chairs, Prof Simon Redwood (Guy’s and St Thomas’ NHS Foundation Trust, London, UK) and Dr Clare Appleby (Liverpool Heart and Chest Hospital, Liverpool, UK) ask the question “Should TAVI be the default treatment for patients with symptomatic aortic stenosis?". From BCIS ACI’s audience and introducing the panel of the debate.

Part 2

Pro Argument

Prof David Hildick-Smith (Sussex Cardiac Centre, Brighton, UK) argues for an interventional approach in the treatment of patients with symptomatic aortic stenosis.

Part 3

Contra Argument

Prof Marjan Jahangiri (St George's University Hospitals NHS Foundation Trust, London, UK) argues that surgery, SAVR should be considered based on life expectancy in the treatment of patients with symptomatic aortic stenosis.

Part 4

Panel Discussion

The panel and the chairs conclude the debate by reflecting on recent data and the arguments delivered by Prof Marjan Jahangiri (St George's University Hospitals NHS Foundation Trust, London, UK) and Prof David Hildick-Smith (Sussex Cardiac Centre, Brighton, UK).

Faculty Biographies

David Hildick-Smith

David Hildick-Smith

MD

David Hildick-Smith is a Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre. He is Director of the Cardiac Research, ex-Treasurer of the British Cardiovascular Interventions Society, and has more than 15 years experience of Interventional Cardiology.

View full profile